Evidence map›Paper›PMID 42539970›Full record

ArticleEULAR rheumatology open2026

Patient awareness and perception of cardiovascular risk in rheumatic and musculoskeletal diseases: results from an international survey.

Alessia Alunno, Javier Rodríguez-Carrio, Sander van Leuven, Valentin Ritschl, Valentina Schmolik, Peter Böhm, Francesca Marchiori, Karen Schreiber, Dina Husum, Tanja Stamm and 5 more

Abstract read
In one paragraph

Article in EULAR rheumatology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alessia AlunnoDepartment of Clinical Medicine, Life, Health and Environmental Science, Internal Medicine and Nephrology Division, University of L'Aquila, L'Aquila, Italy.
Javier Rodríguez-CarrioArea of Immunology, Department of Functional Biology, Faculty of Medicine, University of Oviedo, Oviedo, Spain.
Sander van LeuvenDepartment of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Valentin RitschlInstitute of Outcomes Research, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
Valentina SchmolikInstitute of Outcomes Research, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
Peter BöhmEULAR PARE, Zurich, Switzerland.
Francesca MarchioriEULAR PARE, Zurich, Switzerland.
Karen SchreiberDanish Center for Expertise in Rheumatology (CeViG), Danish Hospital for Rheumatic Diseases, University Hospital of Southern Jutland, Sonderborg, Denmark.
Dina HusumDanish Center for Expertise in Rheumatology (CeViG), Danish Hospital for Rheumatic Diseases, University Hospital of Southern Jutland, Sonderborg, Denmark.
Tanja StammInstitute of Outcomes Research, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
Gabriella SzucsDepartment of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Fabiola AtzeniRheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, Italy.
Zoltan SzekaneczDepartment of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Michael NurmohamedDepartment of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
EULAR Cardiovascular in inflammatory arthritis (CVIIA) Study Group members

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Inflammatory rheumatic and musculoskeletal diseases (RMDs) are hallmarked by an increased risk of cardiovascular (CV) disease compared with the general population. Evidence suggests that CV risk remains under-recognised and underdiscussed in routine care, although data on patient experience is lacking. We aimed to assess awareness, perceptions, and experiences regarding CV risk and prevention in patients with RMDs. Methods: An anonymous, online survey was codesigned by rheumatologists, researchers, and patient research partners in English language and translated into 9 languages. This was distributed through patient organisations/forums and social media. Results: A total of 951 patients with RMDs from 43 countries (mainly females, aged 50-70 years, and with a diagnosis of rheumatoid arthritis, spondyloarthritis, or systemic lupus erythematosus) completed the survey. Although 68% of respondents acknowledged an increased CV risk in RMDs, and traditional CV risk factors were recognised by up to 60% of the participants, knowledge of disease-specific contributors (eg, disease activity) to CV risk was limited. Only 35% of respondents had ever discussed CV risk with a healthcare provider, mainly rheumatologists or cardiologists, and the content primarily focused on lifestyle advice. Lack of awareness on the topic relevance (38%), perceived complexity of the topic (25%), limited time of clinical visits (35%), and lack of informative materials (33%) emerged as the main key barriers among those poorly/not informed. Conclusions: This large, multinational survey demonstrates substantial gaps in CV risk awareness, knowledge, and patient-provider communication among patients with RMDs. These figures support the development of structured, patient-centred educational strategies and enhanced multidisciplinary communication schemes to improve CV prevention in RMDs.

Identifiers

PMID42539970
PMCPMC13424985

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.